BIOSIG TECHNOLOGIES INC

NASDAQ: BSGM (BioSig Technologies, Inc.)

Last update: 07 Feb, 8:02PM

0.909

-0.02 (-2.38%)

Previous Close 0.931
Open 0.901
Volume 238,364
Avg. Volume (3M) 215,316
Market Cap 16,011,239
Price / Sales 317.95
Price / Book 36.58
52 Weeks Range
0.201 (-77%) — 2.98 (227%)
Earnings Date 14 Apr 2025 - 27 Apr 2025
Operating Margin (TTM) -40,707.69%
Diluted EPS (TTM) -1.34
Quarterly Revenue Growth (YOY) 180.00%
Total Debt/Equity (MRQ) 243.10%
Current Ratio (MRQ) 0.800
Operating Cash Flow (TTM) -9.56 M
Levered Free Cash Flow (TTM) -4.40 M
Return on Assets (TTM) -326.50%
Return on Equity (TTM) -6,342.03%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock BioSig Technologies, Inc. Bearish Bearish

AIStockmoo Score

-1.3
Analyst Consensus -0.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average -1.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BSGM 16 M - - 36.58
QDEL 3 B - - 0.920
IART 2 B - - 1.13
AHCO 1 B - - 0.830
OFIX 706 M - - 1.34
LAB 659 M - - 1.12

BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare’s biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.

Sector Healthcare
Industry Medical Devices
Investment Style Small Value
% Held by Insiders 30.77%

Ownership

Name Date Shares Held
Cornerstone Planning Group Llc 31 Dec 2024 5,000
Riverview Trust Co 31 Dec 2024 60
Steward Partners Investment Advisory, Llc 31 Dec 2024 50
Robbins Farley 31 Dec 2024 8
52 Weeks Range
0.201 (-77%) — 2.98 (227%)
Median 2.75 (202.60%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Ascendiant Capital 05 Dec 2024 2.75 (202.60%) Buy 1.47

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria